M

Myungmoon Pharm Co Ltd
KRX:017180

Watchlist Manager
Myungmoon Pharm Co Ltd
KRX:017180
Watchlist
Price: 1 810 KRW 0.39% Market Closed
Market Cap: ₩61.4B

Operating Margin

3.6%
Current
Improving
by 1.9%
vs 3-y average of 1.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
3.6%
=
Operating Income
₩7B
/
Revenue
₩193.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
3.6%
=
Operating Income
₩7B
/
Revenue
₩193.6B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Myungmoon Pharm Co Ltd
KRX:017180
60.5B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in Korea
Percentile
56th
Based on 2 615 companies
56th percentile
3.6%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Myungmoon Pharm Co Ltd
Glance View

Market Cap
61.4B KRW
Industry
Pharmaceuticals

MYUNGMOON Pharm Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2008-07-10. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The firm is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.

Myungmoon Pharm Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
3.6%
=
Operating Income
₩7B
/
Revenue
₩193.6B
What is Myungmoon Pharm Co Ltd's current Operating Margin?

The current Operating Margin for Myungmoon Pharm Co Ltd is 3.6%, which is above its 3-year median of 1.7%.

How has Operating Margin changed over time?

Over the last 3 years, Myungmoon Pharm Co Ltd’s Operating Margin has increased from -2.7% to 3.6%. During this period, it reached a low of -2.7% on Aug 30, 2022 and a high of 5.3% on Mar 31, 2023.

Back to Top